Xiulin Yi

Myricetin: a potent approach for the treatment of type 2 diabetes as a natural class B GPCR agonist

Ying Li, Xuemin Zheng, Xiulin Yi et al. · The FASEB Journal · 2017 · 78 citations · Full text

Combination of <scp>l</scp>-Carnitine with Lipophilic Linkage-Donating Gemcitabine Derivatives as Intestinal Novel Organic Cation Transporter 2-Targeting Oral Prodrugs

Gang Wang, Hongxiang Chen, Dongyang Zhao et al. · Journal of Medicinal Chemistry · 2017 · 50 citations

Medicinal Chemistry, Pharmaceutical Science, Oral Prodrugs +11

Protease-Triggered, Spatially Controlled DNA Assembly in Apoptotic Cells for Early Evaluation of Therapeutic Efficacy

Zhenghan Di, Xiulin Yi, Lele Li · Journal of the American Chemical Society · 2023 · 44 citations

Early Evaluation, Peptide Engineering, Apoptosis +20

Aspartate‐modified doxorubicin on its <i>N</i>‐terminal increases drug accumulation in <i><scp>LAT</scp>1</i>‐overexpressing tumors

Weidang Wu, Yan Dong, Jing Gao et al. · Cancer Science · 2015 · 29 citations · Full text

Aspartate‐modified Doxorubicin, Peptide Science, Immunotherapeutics +17

Potential detoxification effect of active ingredients in liquorice by upregulating efflux transporter

Yufei He, Xiaoyan Ci, Ying Xie et al. · Phytomedicine · 2018 · 27 citations

Potential Detoxification Effect, Environmental Engineering, Medicine +5